CD274 and neoplasm: However, other studies such as CheckMate-040, which preceded CheckMate-459 and evaluated both nivolumab monotherapy and nivolumab plus ipilimumab combination therapy in different study cohorts, did not show a clear predictive effect of tumor cell PD-L1 expression on response.